Skip to content
OpenCapital
Get started

Celldex Therapeutics CLDX Enterprise value

Enterprise value at other companies

Eli Lilly logo
Eli LillyLLY
$859.77B+10.6%
Pfizer logo
PfizerPFE
$222.4B+9.2%
Rogers Corporation logo
Rogers CorporationROG
$1.75B+57.7%
Amgen logo
AmgenAMGN
$246.43B+9.9%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.42B+18.1%
Incyte logo
IncyteINCY
$15.31B+55.9%

Other financials

Income statement

See full
Revenue$15.0K-97.8%
Operating income-$84.4M-34.6%
Net income-$78.7M-46.3%
EPS (diluted)-$1.18-45.7%

Balance sheet

See full
Cash & equivalents$35.7M+109%
Total debt$1.9M-44.3%
Total equity$456.2M-35.1%
Total assets$511.3M-30.9%

Cash flow

See full
Operating cash flow-$65.6M-20.6%
CapEx$1.6M+518%
Free cash flow-$67.2M-23.0%

Valuation

See full
Market cap$2.59B+75.2%
P/S2,989.2×+2,794×

Profitability

See full
Operating margin-35,688.5%-39,114pp
Net margin-32,753.6%-35,519pp
FCF margin-26,125.8%-28,907pp

Returns & leverage

See full
Return on equity-48.9%-498pp
Debt / equity0×0.0×
Current ratio8.9×-12.7×

Where this comes from

Calculated from Celldex Therapeutics’s reported figures.

$2.1Bmarket cap+$1.9Mtotal debt−$35.7Mcash and equivalents=$2.08B

The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celldex Therapeutics's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celldex Therapeutics's enterprise value?
Celldex Therapeutics (CLDX) reported enterprise value of $2.08B in Q1 2026.
How has Celldex Therapeutics's enterprise value changed year-over-year?
Celldex Therapeutics's enterprise value increased by 74.4% year-over-year, from $1.19B to $2.08B.
What is the long-term trend for Celldex Therapeutics's enterprise value?
Over 5 years (2020 to 2025), Celldex Therapeutics's enterprise value has grown at a 18.0% compound annual growth rate (CAGR), from $777.2M to $1.78B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.